Mission Bio, the life sciences company delivering single-cell resolution multi-omics tools to accelerate discoveries and improve time-to-market for new therapeutics, revealed that a recently published paper in Cancer Cell made use of its Tapestri Platform to profile samples taken from melanoma for the first time.
You Might Also Like
Proteintech Triples Its Size of Headquarters to Expand Operations and Meet Demand
Oxford Nanopore announces breakthrough technology performance to deliver complete human genome assemblies and richer multiomic data in London Calling tech update
